We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+5.68%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$20.9B
AUM Growth
+$2.54B
Cap. Flow
+$1.55B
Cap. Flow %
7.41%
Top 10 Hldgs %
15.24%
Holding
2,978
New
379
Increased
824
Reduced
813
Closed
161

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$798M
2
XOM icon
ExxonMobil
XOM
+$189M
3
CTSH icon
Cognizant
CTSH
+$86.4M
4
MRK icon
Merck
MRK
+$80.6M
5
IART icon
Integra LifeSciences
IART
+$47.9M

Top Sells

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$57.5M
2
PEP icon
PepsiCo
PEP
+$55.1M
3
DG icon
Dollar General
DG
+$49.7M
4
WOOF
VCA Inc.
WOOF
+$48.1M
5
SPG icon
Simon Property Group
SPG
+$45.6M

Sector Composition

Rank Sector Weight
1 Healthcare 17.52%
2 Technology 14.11%
3 Financials 12.07%
4 Industrials 10.58%
5 Consumer Discretionary 9.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MAA icon
1001
Mid-America Apartment Communities
MAA
$15.7B
$263K ﹤0.01%
2,595
-292,342
-99% -$28.9M
MTRN icon
1002
Materion
MTRN
$5.02B
$263K ﹤0.01%
7,867
WOOF
1003
DELISTED
VCA Inc.
WOOF
$262K ﹤0.01%
2,878
-536,633
-99% -$48.1M
BIO icon
1004
Bio-Rad Laboratories Class A
BIO
$8.52B
$260K ﹤0.01%
1,306
TILT icon
1005
FlexShares Morningstar US Market Factors Tilt Index Fund
TILT
$2.17B
$260K ﹤0.01%
2,600
HXL icon
1006
Hexcel
HXL
$8.25B
$259K ﹤0.01%
4,754
-2,957
-38% -$156K
SPYG icon
1007
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$50.5B
$259K ﹤0.01%
9,120
SLCA
1008
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$259K ﹤0.01%
5,401
-5,649
-51% -$302K
SWN
1009
DELISTED
Southwestern Energy Company
SWN
$257K ﹤0.01%
31,506
+5,300
+20% +$45.9K
BR icon
1010
Broadridge
BR
$17.6B
$255K ﹤0.01%
3,769
MOH icon
1011
Molina Healthcare
MOH
$10.5B
$254K ﹤0.01%
5,584
-5,455
-49% -$285K
BNS icon
1012
Scotiabank
BNS
$106B
$252K ﹤0.01%
4,324
-29
-0.7% -$1.72K
POOL icon
1013
Pool Corp
POOL
$6.74B
$252K ﹤0.01%
2,115
FRC
1014
DELISTED
First Republic Bank
FRC
$250K ﹤0.01%
2,675
-981
-27% -$92.3K
TFSL icon
1015
TFS Financial
TFSL
$5.1B
$249K ﹤0.01%
15,000
ARAV
1016
DELISTED
Aravive, Inc. Common Stock
ARAV
$248K ﹤0.01%
+1,942
New +$205K
ADSK icon
1017
Autodesk
ADSK
$46.6B
$247K ﹤0.01%
2,874
+80
+3% +$6.7K
NEOG icon
1018
Neogen
NEOG
$2.06B
$246K ﹤0.01%
10,051
+227
+2% +$5.56K
PVH icon
1019
PVH
PVH
$3.8B
$246K ﹤0.01%
2,387
-3,783
-61% -$350K
TECH icon
1020
Bio-Techne
TECH
$11.2B
$245K ﹤0.01%
9,684
+1,996
+26% +$51.5K
WU icon
1021
Western Union
WU
$2.57B
$245K ﹤0.01%
12,071
-516
-4% -$10.5K
KSS icon
1022
Kohl's
KSS
$2.07B
$244K ﹤0.01%
6,158
-25,291
-80% -$1.03M
CBT icon
1023
Cabot Corp
CBT
$4.62B
$243K ﹤0.01%
4,070
LNCE
1024
DELISTED
Snyders-Lance, Inc.
LNCE
$243K ﹤0.01%
6,051
+51
+0.9% +$1.99K
HEI.A icon
1025
HEICO Corp Class A
HEI.A
$36.3B
$241K ﹤0.01%
6,295

Similar funds

Glenmede Trust's Q1 2017 Portfolio in Review

As of Q1 2017, Glenmede Trust held 2,978 positions worth $20.9B, up 14% from $18.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Glenmede Trust deployed $1.55B of net new capital in Q1 2017, opening 379 new positions and adding to 824 existing holdings. Its largest new stake was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 13% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Activision Blizzard, an estimated $57.5M trimmed.

  • Glenmede Trust's largest Q1 2017 buy was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.
  • Glenmede Trust added most to Johnson & Johnson in Q1 2017, an estimated $798M increase.
  • Glenmede Trust's biggest Q1 2017 reduction was Activision Blizzard, cutting an estimated $57.5M.
  • Glenmede Trust fully exited Cynosure, Inc. Class A in Q1 2017, selling an estimated $22.5M.
  • Glenmede Trust's ten largest holdings make up 15% of its $20.9B portfolio in Q1 2017.
  • Glenmede Trust opened 379 new positions and closed 161 in Q1 2017.
  • Glenmede Trust's portfolio value rose 14% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q1 2017, filed 15 May 2017.